New patent for Boehringer Ingelheim drug JENTADUETO XR March 27, 2024 AutoBot News 0 Annual Drug Patent Expirations for JENTADUETO+XR Jentadueto Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are eight… Source